Ruzzene M - Search Results

1

How can a traffic light properly work if it is always green? The paradox of CK2 signaling.

Borgo C, D'Amore C, Cesaro L, Sarno S, Pinna LA, Ruzzene M, Salvi M. Borgo C, et al. Among authors: ruzzene m. Crit Rev Biochem Mol Biol. 2021 Aug;56(4):321-359. doi: 10.1080/10409238.2021.1908951. Epub 2021 Apr 11. Crit Rev Biochem Mol Biol. 2021. PMID: 33843388 Review.

2

Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.

Meggio F, Pagano MA, Moro S, Zagotto G, Ruzzene M, Sarno S, Cozza G, Bain J, Elliott M, Deana AD, Brunati AM, Pinna LA. Meggio F, et al. Among authors: ruzzene m. Biochemistry. 2004 Oct 12;43(40):12931-6. doi: 10.1021/bi048999g. Biochemistry. 2004. PMID: 15461466 Free article.

3

Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis.

Di Maira G, Brustolon F, Tosoni K, Belli S, Krämer SD, Pinna LA, Ruzzene M. Di Maira G, et al. Among authors: ruzzene m. Mol Cell Biochem. 2008 Sep;316(1-2):155-61. doi: 10.1007/s11010-008-9813-6. Epub 2008 Jun 17. Mol Cell Biochem. 2008. PMID: 18560764

4

Addiction to protein kinase CK2: a common denominator of diverse cancer cells?

Ruzzene M, Pinna LA. Ruzzene M, et al. Biochim Biophys Acta. 2010 Mar;1804(3):499-504. doi: 10.1016/j.bbapap.2009.07.018. Epub 2009 Aug 6. Biochim Biophys Acta. 2010. PMID: 19665589 Review.

5

Assessment of CK2 constitutive activity in cancer cells.

Ruzzene M, Di Maira G, Tosoni K, Pinna LA. Ruzzene M, et al. Methods Enzymol. 2010;484:495-514. doi: 10.1016/B978-0-12-381298-8.00024-1. Methods Enzymol. 2010. PMID: 21036247

6

The p23 co-chaperone protein is a novel substrate of CK2 in Arabidopsis.

Tosoni K, Costa A, Sarno S, D'Alessandro S, Sparla F, Pinna LA, Zottini M, Ruzzene M. Tosoni K, et al. Among authors: ruzzene m. Mol Cell Biochem. 2011 Oct;356(1-2):245-54. doi: 10.1007/s11010-011-0969-0. Epub 2011 Jul 7. Mol Cell Biochem. 2011. PMID: 21735091

7

Protein kinase CK2 accumulation in "oncophilic" cells: causes and effects.

Ruzzene M, Tosoni K, Zanin S, Cesaro L, Pinna LA. Ruzzene M, et al. Mol Cell Biochem. 2011 Oct;356(1-2):5-10. doi: 10.1007/s11010-011-0959-2. Epub 2011 Jul 7. Mol Cell Biochem. 2011. PMID: 21735095

8

Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: biochemical evidence and therapeutic perspectives.

Borgo C, Cesaro L, Salizzato V, Ruzzene M, Massimino ML, Pinna LA, Donella-Deana A. Borgo C, et al. Among authors: ruzzene m. Mol Oncol. 2013 Dec;7(6):1103-15. doi: 10.1016/j.molonc.2013.08.006. Epub 2013 Aug 22. Mol Oncol. 2013. PMID: 24012109 Free PMC article.

9

Role of protein kinase CK2 in antitumor drug resistance.

Borgo C, Ruzzene M. Borgo C, et al. Among authors: ruzzene m. J Exp Clin Cancer Res. 2019 Jul 5;38(1):287. doi: 10.1186/s13046-019-1292-y. J Exp Clin Cancer Res. 2019. PMID: 31277672 Free PMC article. Review.

10

Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor Cells.

Zonta F, Borgo C, Quezada Meza CP, Masgras I, Rasola A, Salvi M, Pinna LA, Ruzzene M. Zonta F, et al. Among authors: ruzzene m. Cells. 2021 Jan 18;10(1):181. doi: 10.3390/cells10010181. Cells. 2021. PMID: 33477590 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page